EUVIMEDEUVIMED entdecken
Kohortenstudie

Early Beta-Blocker Utilization in Critically Ill Patients With Moderate-Severe Traumatic Brain Injury: A Retrospective Cohort Study

Margot Kelly-Hedrick iD, Sunny Yang Liu, Jordan Komisarow iD, Jordan Hatfield, Tetsu Ohnuma, Miriam M Treggiari iD, Katharine Colton, Evangeline Arulraja, Monica S Vavilala, Daniel T Laskowitz, Joseph P Mathew, Adrian Hernandez und 3 weitere

Journal of Intensive Care Medicine · 2024-09 · 39 (9) · 875-882

DOI: 10.1177/08850666241236724 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Intensive Care Medicine, online erschienen am 06.03.2024. Verfasst von Margot Kelly-Hedrick und 14 weiteren Autor:innen. Beteiligte Einrichtung: Critical Care and Perioperative Population Health Research (CAPER) Program, Department of Anesthesiology, Duke University, Durham, NC, USA. Hauptthemen laut MEDLINE: Adrenergic beta-Antagonists, Brain Injuries, Traumatic, Critical Illness, Length of Stay. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: National Institute of Neurological Disorders and Stroke.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is limited evidence that beta-blockers may provide benefit for patients with moderate-severe traumatic brain injury (TBI) during the acute injury period. Larger studies on utilization patterns and impact on outcomes in clinical practice are lacking.

Objective

The present study uses a large, national hospital claims-based dataset to examine early beta-blocker utilization patterns and its association with clinical outcomes among critically ill patients with moderate-severe TBI.

Methods

We conducted a retrospective cohort study of the administrative claims Premier Healthcare Database of adults (≥17 years) with moderate-severe TBI admitted to the intensive care unit (ICU) from 2016 to 2020. The exposure was receipt of a beta-blocker during day 1 or 2 of ICU stay (BB + ). The primary outcome was hospital mortality, and secondary outcomes were: hospital length of stay (LOS), ICU LOS, discharge to home, and vasopressor utilization. In a sensitivity analysis, we explored the association of beta-blocker class (cardioselective and noncardioselective) with hospital mortality. We used propensity weighting methods to address possible confounding by treatment indication.

Results

A total of 109 665 participants met inclusion criteria and 39% (n = 42 489) were exposed to beta-blockers during the first 2 days of hospitalization. Of those, 42% received cardioselective only, 43% received noncardioselective only, and 14% received both. After adjustment, there was no association with hospital mortality in the BB + group compared to the BB − group (adjusted odds ratio [OR] = 0.99, 95% confidence interval [CI] = 0.94, 1.04). The BB + group had longer hospital stays, lower chance of discharged home, and lower risk of vasopressor utilization, although these difference were clinically small. Beta-blocker class was not associated with hospital mortality.

Conclusion

In this retrospective cohort study, we found variation in use of beta-blockers and early exposure was not associated with hospital mortality. Further research is necessary to understand the optimal type, dose, and timing of beta-blockers for this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenergic beta-AntagonistsBrain Injuries, TraumaticCritical IllnessLength of StayHospital MortalityIntensive Care UnitsHumansRetrospective StudiesMaleFemaleMiddle AgedAdultAgedPropensity Score

Stichwörter der Autor:innen

beta-blockersshocktraumatic brain injuryvasopressors

Substanzen

Adrenergic beta-Antagonists

Autor:innen und Institutionen

  • Critical Care and Perioperative Population Health Research (CAPER) Program, Department of Anesthesiology, Duke University, Durham, NC, USA.
  • Duke University School of Medicine, Durham, NC, USA.
  • Department of Neurosurgery, Duke University, Durham, NC, USA.
  • Department of Anesthesiology, Duke University, Durham, NC, USA.
  • Department of Population Health Sciences, Duke University, Durham, NC, USA.
  • Department of Neurology, Duke University, Durham, NC, USA.

ORCID-Profile: Margot Kelly-Hedrick, Jordan Komisarow, Miriam M Treggiari, Vijay Krishnamoorthy

Förderung

  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Kelly-Hedrick, M., Liu, S. Y., Komisarow, J., Hatfield, J., Ohnuma, T., Treggiari, M. M., Colton, K., Arulraja, E., Vavilala, M. S., Laskowitz, D. T., Mathew, J. P., Hernandez, A., James, M. L., Raghunathan, K., & Krishnamoorthy, V. (2024). Early Beta-Blocker Utilization in Critically Ill Patients With Moderate-Severe Traumatic Brain Injury: A Retrospective Cohort Study. Journal of Intensive Care Medicine, 39(9), 875-882. https://doi.org/10.1177/08850666241236724

Vancouver

Kelly-Hedrick M, Liu SY, Komisarow J, Hatfield J, Ohnuma T, Treggiari MM, et al. Early Beta-Blocker Utilization in Critically Ill Patients With Moderate-Severe Traumatic Brain Injury: A Retrospective Cohort Study. Journal of Intensive Care Medicine. 2024;39(9):875-882. doi:10.1177/08850666241236724

BibTeX
@article{KellyHedrick2024,
  author = {Kelly-Hedrick, Margot and Liu, Sunny Yang and Komisarow, Jordan and Hatfield, Jordan and Ohnuma, Tetsu and Treggiari, Miriam M and Colton, Katharine and Arulraja, Evangeline and Vavilala, Monica S and Laskowitz, Daniel T and Mathew, Joseph P and Hernandez, Adrian and James, Michael L and Raghunathan, Karthik and Krishnamoorthy, Vijay},
  title = {Early Beta-Blocker Utilization in Critically Ill Patients With Moderate-Severe Traumatic Brain Injury: A Retrospective Cohort Study},
  journal = {Journal of Intensive Care Medicine},
  year = {2024},
  volume = {39},
  number = {9},
  pages = {875--882},
  doi = {10.1177/08850666241236724}
}
Kostenlos starten →